Literature DB >> 9171168

Functional characterization of NGF-secreting cell grafts to the acutely injured spinal cord.

M H Tuszynski1, K Murai, A Blesch, R Grill, I Miller.   

Abstract

Previously we reported that grafts of cells genetically modified to produce human nerve growth factor (hNGF) promoted specific and robust sprouting of spinal sensory, motor, and noradrenergic axons. In the present study we extend these investigations to assess NGF effects on corticospinal motor axons and on functional outcomes after spinal cord injury. Fibroblasts from adult rats were transduced to express human NGF; control cells were not genetically modified. Fibroblasts were then grafted to sites of midthoracic spinal cord dorsal hemisection lesions. Three months later, recipients of NGF-secreting grafts showed deficits on conditioned locomotion over a wire mesh that did not differ in extent from control-lesioned animals. On histological examination, NGF-secreting grafts elicited specific sprouting from spinal primary sensory afferent axons, local motor axons, and putative cerulospinal axons as previously reported, but no specific responses from corticospinal axons. Axons responding to NGF robustly penetrated the grafts but did not exit the grafts to extend to normal innervation territories distal to grafts. Grafted cells continued to express NGF protein through the experimental period of the study. These findings indicate that 1) spinal cord axons show directionally sensitive growth responses to neurotrophic factors, 2) growth of axons responding to a neurotrophic factor beyond an injury site and back to their natural target regions will likely require delivery of concentration gradients of neurotrophic factors toward the target, 3) corticospinal axons do not grow toward a cellular source of NGF, and 4) functional impairments are not improved by strictly local sprouting response of nonmotor systems.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9171168     DOI: 10.1177/096368979700600318

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.139


  10 in total

Review 1.  Neurotrophic factors, cellular bridges and gene therapy for spinal cord injury.

Authors:  L L Jones; M Oudega; M B Bunge; M H Tuszynski
Journal:  J Physiol       Date:  2001-05-15       Impact factor: 5.182

2.  Impact of treatment duration and lesion size on effectiveness of chondroitinase treatment post-SCI.

Authors:  S E Mondello; S C Jefferson; N J Tester; D R Howland
Journal:  Exp Neurol       Date:  2015-02-26       Impact factor: 5.330

3.  Cellular delivery of neurotrophin-3 promotes corticospinal axonal growth and partial functional recovery after spinal cord injury.

Authors:  R Grill; K Murai; A Blesch; F H Gage; M H Tuszynski
Journal:  J Neurosci       Date:  1997-07-15       Impact factor: 6.167

Review 4.  Recent therapeutic strategies for spinal cord injury treatment: possible role of stem cells.

Authors:  D Garbossa; M Boido; M Fontanella; C Fronda; A Ducati; A Vercelli
Journal:  Neurosurg Rev       Date:  2012-04-27       Impact factor: 3.042

5.  Immature astrocytes promote CNS axonal regeneration when combined with chondroitinase ABC.

Authors:  Angela R Filous; Jared H Miller; Yvette M Coulson-Thomas; Kevin P Horn; Warren J Alilain; Jerry Silver
Journal:  Dev Neurobiol       Date:  2010-10       Impact factor: 3.964

6.  Axonal regeneration and functional recovery after complete spinal cord transection in rats by delayed treatment with transplants and neurotrophins.

Authors:  J V Coumans; T T Lin; H N Dai; L MacArthur; M McAtee; C Nash; B S Bregman
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

Review 7.  Chemical priming for spinal cord injury: a review of the literature part II-potential therapeutics.

Authors:  Martin M Mortazavi; Ketan Verma; Aman Deep; Fatemeh B Esfahani; Patrick R Pritchard; R Shane Tubbs; Nicholas Theodore
Journal:  Childs Nerv Syst       Date:  2010-12-21       Impact factor: 1.475

Review 8.  CNS injury, glial scars, and inflammation: Inhibitory extracellular matrices and regeneration failure.

Authors:  Michael T Fitch; Jerry Silver
Journal:  Exp Neurol       Date:  2007-05-31       Impact factor: 5.330

Review 9.  Biodegradable biomatrices and bridging the injured spinal cord: the corticospinal tract as a proof of principle.

Authors:  Elbert A J Joosten
Journal:  Cell Tissue Res       Date:  2012-03-14       Impact factor: 5.249

10.  Panax notoginseng saponins improve recovery after spinal cord transection by upregulating neurotrophic factors.

Authors:  Bo Wang; Yu Li; Xuan-Peng Li; Yang Li
Journal:  Neural Regen Res       Date:  2015-08       Impact factor: 5.135

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.